导管消融在室性心动过速治疗中的作用。
The role of catheter ablation in the management of ventricular tachycardia.
机构信息
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
出版信息
Eur Heart J. 2016 Feb 14;37(7):594-609. doi: 10.1093/eurheartj/ehv421. Epub 2015 Aug 31.
The treatment strategy for ventricular tachycardia (VT) is guided by patient symptoms, the risk of sudden death estimated by VT mechanism and underlying cardiac structure, and the risk vs. benefit ratio of potential therapies. Over the last few decades, catheter ablation has emerged as the primary treatment of idiopathic VT and become an important management strategy in reducing VT burden in patients with structural heart disease. This article reviews the technique and outcomes of catheter ablation for ventricular arrhythmias as well as potential future directions for this procedure.
室性心动过速（VT）的治疗策略取决于患者症状、VT 机制和潜在心脏结构估计的猝死风险，以及潜在治疗方法的风险与获益比。在过去几十年中，导管消融已成为特发性 VT 的主要治疗方法，并成为结构性心脏病患者降低 VT 负荷的重要管理策略。本文回顾了导管消融治疗室性心律失常的技术和结果，以及该手术的潜在未来方向。
Zotero 插件